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Abstract. 
 
The matrix metalloproteinase MMP-3/stro-
melysin-1 (Str1) is highly expressed during mammary
gland involution induced by weaning. During involu-
tion, programmed cell death of the secretory epithe-
lium takes place concomitant with the repopulation of
the mammary fat pad with adipocytes. In this study, we
have used a genetic approach to determine the role of
Str1 during mammary involution. Although Str1 has
been shown to induce unscheduled apoptosis when ex-
pressed ectopically during late pregnancy (Alexander,
 
C.M., E.W. Howard, M.J. Bissell, and Z. Werb. 1996. 
 
J.
Cell Biol
 
. 135:1669–1677), we found that during post-
lactational involution, mammary glands from trans-
genic mice that overexpress the tissue inhibitor of me-
 
talloproteinases, TIMP-1 (TO), or mice carrying a targeted
mutation in 
 
Str1 
 
showed accelerated differentiation and
hypertrophy of adipocytes, while epithelial apoptosis
was unaffected. These data suggest that matrix metallo-
proteinases (MMPs) do not induce unscheduled epithe-
lial cell death after weaning, but instead alter the stro-
mal microenvironment. We used adipogenic 3T3-L1
cells as a cell culture model to test the function of
MMPs during adipocyte differentiation. Fibroblastic
3T3-L1 progenitor cells expressed very low levels of
MMPs or TIMPs. The transcription of a number of
MMP and TIMP mRNAs [Str1, MT1-MMP, (MMP-14)
collagenase-3 (MMP-13), gelatinase A (MMP-2), and
TIMP-1, -2 and -3] was induced in committed preadipo-
cytes, but only differentiated adipocytes expressed an
activated MMP, gelatinase A. The addition of MMP in-
hibitors (GM 6001 and TIMP-1) dramatically acceler-
ated the accumulation of lipid during differentiation.
We conclude that MMPs, especially Str1, determine the
rate of adipocyte differentiation during involutive
mammary gland remodeling.
Key words: transgenic mouse • mammary involution
• MMP-3 • TIMP-1 • 3T3-L1 adipocytes
 
Introduction
 
When pups are removed from a lactating mouse, the mam-
mary glands involute, losing the expression of the differen-
tiated gene products associated with milk production and
resulting in the loss of at least 90% of the lactating mam-
mary epithelial cell number. Using this model of induced
apoptosis in adult mice, we can determine physiologically
relevant factors that control epithelial cell death. Mam-
mary gland involution is a two-phase process. The first
phase is characterized by the onset of epithelial apoptosis,
which is p53 dependent (Jerry et al., 1998), and the second
phase by upregulation of proteinases, repopulation of the
mammary stroma by adipocytes, and completion of epi-
thelial programmed cell death in a p53-independent man-
ner (Li et al., 1996; Lund et al., 1996).
In cultured mammary epithelial cells, epithelial apopto-
sis is induced by expression of matrix metalloproteinases
(MMPs),
 
1
 
 by the inhibition of integrin-mediated adhesion,
or by altering cell cycle progression (Boudreau et al., 1995,
1996; Wang et al., 1994; Wiesen and Werb, 2000). When
stromelysin-1 (Str1) is misexpressed in mammary gland by
transgenic means, mice show precocious growth of virgin
gland to a mid-pregnant equivalent (Sympson et al., 1994),
stromal alteration, and unscheduled apoptosis during
pregnancy (Boudreau et al., 1995; Alexander et al., 1996;
Thomasset et al., 1998) and tumor formation (Sternlicht et
al., 1999). Therefore, we hypothesize that the response of
mammary epithelial cells to ectopic Str1 reflects normal
roles for this enzyme.
The prototype MMP, collagenase, was isolated as a col-
lagenolytic activity specifically induced during involution
of the tadpole tail (Gross, 1966). Since the description of
this activity, other MMPs have been shown to be induced
during physiological remodeling reactions and to cleave
structural proteins important to maintaining basement
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 dpc, days post coitum; ECM, extracellu-
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Str1, stromelysin-1/MMP-3; TIMP, tissue inhibitor of metalloproteinases;
TO, TIMP overexpressing transgenic mouse; WAP, whey acidic protein. 
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membrane integrity (Sternlicht and Werb, 1999; Sternlicht
et al., 1999; Vu and Werb, 2000). One such MMP, Str1, is
expressed and regulated during mammary gland develop-
ment and involution (Witty et al., 1995). Str1 cleaves many
basement membrane proteins (Mayer et al., 1993; Werb,
1997), and can autoactivate pro-Str1 and other pro-MMPs
to initiate a proteolytic cascade (Nagase, 1997). It is syn-
thesized and secreted by a subpopulation of stromal cells
in mammary gland (Witty et al., 1995). Targets for protein-
ase activity are not limited to extracellular matrix (ECM)
molecules. Cell surface molecules such as E-cadherin can
be cleaved in cultured mammary epithelial cells trans-
fected with an inducible Str1 cDNA (Lochter et al., 1997;
Werb, 1997; Sternlicht and Werb 2000). Other substrates
include extracellular growth factors and cell-surface mole-
cules (Werb, 1997).
To test the importance of MMPs in involution in the
present study, we have used two genetic approaches. We
have investigated mammary gland involution in mice over-
expressing the tissue inhibitor of matrix metalloprotein-
ases, human TIMP-1 (TO) (Alexander et al., 1996), and in
mice carrying a null mutation in 
 
Str1 (Str1
 
2
 
/
 
2
 
)
 
 (Mudgett
et al., 1998). Both of these transgenic mice have no overt
defects and are able to complete pregnancy and lactate.
Analysis of mammary glands from TO mice shows that the
transgene is expressed and active (Alexander et al., 1996).
By combining the information from these two strains, we
can identify processes that require Str1 activity (if both
TO and 
 
Str1
 
2
 
/
 
2
 
 transgenic mice share the same pheno-
type) and those that require TIMP-1–inhibitable MMP ac-
tivity (if TO but not 
 
Str1
 
2
 
/
 
2
 
 mice show a specific pheno-
type). We show here that a Str1 deficiency specifically
accelerates the differentiation of adipocytes during active
remodeling, and that epithelial cell death is unaffected in
either transgenic strain.
 
Materials and Methods
 
Materials
 
Ultraspec RNA isolation solution was from Biotecx. Enhanced chemilu-
minescence reagents were from Amersham Pharmacia Biotech. Immo-
bilon P was from Millipore. Sources of antibodies were as follows: rabbit
polyclonal anti–laminin antibody was from Collaborative Research (No.
40023); rat monoclonal anti–entactin (nidogen-1) antibody was from Up-
state Biotechnology Inc. (No. 05-208); HRP-conjugated anti–rabbit (NA
9340) or anti–rat IgC (NA 9320) were from Amersham Pharmacia Bio-
tech. Duralon-UV membrane was from Stratagene. The source of mouse
cDNA probes was as follows: stromelysin-1 (Ostrowski et al., 1988), MT-1
MMP (Sato et al., 1994), pPAR
 
g
 
 (Tontonoz et al., 1995), TIMP-1 (Gewert
et al., 1987), TIMP-2 (a 360-bp coding sequence made by reverse tran-
scription–PCR from published sequence using oligonucleotide sequences
GGTCTCGCTGGACATTGGAGGAAAG and GGGTCCTCGAT-
GTCGAGAAACTCCTG), TIMP-3 (Leco et al., 1994), TIMP-4 (Leco et
al., 1997), vimentin (Capetanaki et al., 1990), and cytokeratin 18 (Kulesh
and Oshima, 1988). 3T3-L1 cells were from the American Type Culture
Collection. GM6001 [3-(
 
N
 
-hydroxycarbamoyl-2(R)–isobutyl propionyl-
 
L
 
-tryptophan methylamide] was a gift of Dr. Richard Galardy (Glycomed
Inc., Alameda, CA). Recombinant human TIMP-1 (rhTIMP-1) was a gift
of Synergen Corp.; human TIMP-1 (hTIMP-1) purified from transfected
BHK cells was a gift of Dr. Joni Mott (Lawrence Berkeley National Labo-
ratory, Berkeley, CA).
 
Transgenic Mice
 
The derivation and characteristics of the transgenic mice expressing a hu-
man TIMP-1 transgene (TO mice) under the control of the 
 
b
 
-actin pro-
 
moter have been described (Alexander et al., 1996). In brief, these mice
have no gross phenotype and express 
 
z
 
50 ng/ml circulating human TIMP-1
and 
 
z
 
20 ng/ml of tissue lysate from pregnant mammary gland. Mice carry-
ing this transgene were compared with nontransgenic sibs or CD-1 control
mice (Charles River Laboratories). Mice carrying a targeted null mutation
in the Str1 gene (
 
Strl
 
2
 
/
 
2
 
) were made by homologous recombination us-
ing the AB2.1 ES cell line from 129 mice (Mudgett et al., 1998), and were
compared with a control line (
 
Str1
 
1
 
/
 
1
 
) on the 129 background. These
mice were also grossly normal. To standardize lactation from mouse to
mouse, litters were adjusted to six pups per dam, and mothers were
housed individually before weaning. For time points during pregnancy, 0.5
days post coitum (dpc) is assumed to be noon of the day of observation of
the vaginal plug. Lactation is timed from the time of parturition.
 
Histology and Immunochemistry
 
For histologic evaluation, pieces of mammary gland were fixed in 4%
paraformaldehyde overnight at 4
 
8
 
C, embedded in paraffin, sectioned and
stained with hematoxylin and eosin (H&E) according to standard tech-
niques. For immunostaining of specific ECM molecules, 5 – 10 mm pieces
of fresh mammary gland were infiltrated with 20% sucrose in 1 mM
EDTA, 50 mM Tris pH 7.5 (4
 
8
 
C) and frozen in OCT for cryosectioning.
Sections (6–10
 
 
 
m
 
m) were cut and immediately fixed in 4% freshly pre-
pared paraformaldehyde for 15 min, blocked in 0.1 M glycine (3 
 
3
 
 1 min
in PBS), and then 10% sheep serum in PBS for 30 min at room tempera-
ture. Anti–entactin antibody (diluted 1:1,000 in 3% bovine serum albumin
in Tris-buffered saline) was incubated on sections overnight at 4
 
8
 
C,
washed three times in PBS/0.1% Tween for 5 min, and incubated with sec-
ondary antibody (HRP-conjugated anti–rat IgG, diluted 1:100 into 20%
Carnation skim milk powder in PBS) for 60 min. The wash protocol was
repeated and the sections were counterstained lightly with methylene
blue.
 
Gel Electrophoresis of Mammary Gland Protein Lysates
 
Pieces of mammary gland tissue were homogenized in RIPA buffer (150
mM NaCl, 1% NP-40, 0.5% deoxycholate, 0.1% SDS, 50 mM Tris-HCl,
pH 8.0) at 0.25 mg wet weight/ml. Lysates were spun for 15 min at 4
 
8
 
C in a
microcentrifuge, and insoluble fractions (ECM-enriched fractions) were
washed once in RIPA buffer and boiled into sample buffer containing 5%
SDS as described previously (Alexander et al., 1996). Extracts equivalent
to 8 mg wet weight tissue were separated on 6% SDS-PAGE gels, and ei-
ther stained with Coomassie blue or silver stain, or transferred to Immo-
bilon P for immunoblotting of specific ECM constituents.
 
Assay of Apoptotic DNA Laddering
 
Fragments of mammary tissue (
 
z
 
100 mg) were digested in lysis buffer (0.2
mg/ml proteinase K in 50 mM Tris-HCl, 0.1 M NaCl, 0.1 M EDTA, 1%
SDS, pH 8.0) overnight at 60
 
8
 
C. The crude DNA preparations were ex-
tracted twice with phenol/chloroform and precipitated with propanol for 3
min at room temperature. After one rinse with 70% ethanol, DNA pellets
were redissolved in TE with RNase A at 60
 
8
 
C for 20 min and digested for
30 min at 37
 
8
 
C. 10 
 
m
 
g of DNA was analyzed by electrophoresis on 2%
agarose gels as described previously (Alexander et al., 1996).
 
Northern Blotting
 
Total RNA was isolated by homogenization (using an Omni 2000 Poly-
tron) of pieces (100–200 mg) of mammary tissue or from 3T3-L1 cultures
in Ultraspec solution according to the manufacturer’s instructions. 10 
 
m
 
g
of RNA was separated by standard formaldehyde gel electrophoresis, and
transferred to Duralon membrane for hybridization with specific probes.
 
Culture and Differentiation of 3T3-L1 Cells
 
3T3-L1 fibroblasts (obtained from American Type Culture Collection)
were routinely grown at subconfluence in 10% FCS/DME-H21. To ini-
tiate differentiation, cells were grown to confluence in 10-cm diameter
dishes or 6- or 96-well tissue culture plates. At day 0, a differentiation-
inducing mix was added (DM; 0.22 mM insulin, 0.6 
 
m
 
M dexamethasone,
and 0.5 mM methylisobutylxanthine in culture medium) (Bernlohr et al.,
1984) with or without MMP inhibitors (10
 
 
 
m
 
M GM 6001 or 250 nM
rhTIMP-1 or hTIMP-1 isolated for cell cultures). After 2 d, medium was
replaced with fresh culture medium with or without inhibitors. To evalu-
ate RNA expression in differentiating cultures, actively proliferating cul- 
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tures (preadipocytes; pre), confluent cultures before DM administration
(committed; com), and differentiating adipocytes after treatment with
DM were scraped into Ultraspec solution, and RNA was purified accord-
ing to the manufacturer’s instructions. Cultures were evaluated for lipid
accumulation at 4 d using an Oil Red O stain as follows: cells were fixed in
10% formalin in PBS and stained for 2 h with Oil Red O (Ramirez-Zacar-
ias et al., 1992), washing well with water before and after staining. For
quantification of lipid accumulation, cells were grown in 96-well plates,
the Oil Red O dye was extracted into 100
 
 
 
m
 
l isopropanol, and the absor-
bance of the solution was read at 510 nm.
 
Preparation of Nuclear Extracts and Western Blotting 
for C/EBP
 
b
 
Nuclear extracts were performed essentially as described by Finbloom
 
 
 
et
al
 
. 
 
(1994). 3T3-L1 cells after various treatments were scraped from the
dish and collected by centrifugation at 3,000 
 
g
 
 for 1 min. Cell pellets were
homogenized in Buffer A (20 mM Hepes, pH 7, 10 mM KCl, 10 mM
MgCl
 
2
 
, 20% glycerol, 0.1% NP-40, 0.5 mM DTT, 0.25 mM PMSF). Nuclei
were collected by centrifugation at 3,000 
 
g 
 
for 5 min, the pellet was resus-
pended in Buffer A, layered onto a sucrose cushion (35% sucrose, 100
mM Hepes, pH 7, 20 mM MgCl
 
2
 
) and spun at 3,000 
 
g
 
 for 15 min. The pel-
let was resuspended in Buffer A with 0.3 M NaCl and centrifuged at
10,000 
 
g
 
 for 5 min. The resulting supernatant (containing the nuclear ex-
tract) was analyzed by Western blotting, using a polyclonal rabbit anti–rat
C/EBP
 
b
 
 carboxy-terminal peptide antiserum from Santa Cruz Biotech-
nology, Inc. (SC-150).
 
Results
 
Stromelysin-1 Is Highly Upregulated during Mammary 
Gland Involution
 
The endogenous expression of Str1 mRNA is regulated dur-
ing mammary gland development. Str1 expression was low
in virgin glands, but it was induced during early pregnancy
(3 dpc), continued to increase to 9 dpc, and was not detect-
able after 12 d of pregnancy or during lactation (Fig. 1 a).
Expression of a Str1 transgene during late pregnancy in-
duces unscheduled apoptosis in dividing mammary epithelial
cells (Boudreau et al., 1995; Alexander et al., 1996). Interest-
ingly, the expression of endogenous Str1 mRNA is not de-
tectable during late pregnancy, presumably protecting cells
from Str1-induced cell death. Str1 mRNA was highly in-
duced during involution, when the secretory epithelium un-
dergoes apoptosis (Talhouk et al., 1992; Li et al., 1994; Lund
et al., 1996), to 
 
z
 
50-fold that typical of pregnant glands.
During mammary development induced by pregnancy,
the expression of mRNA for the matrix metalloproteinase
inhibitor, TIMP-1, is induced beginning at 6 dpc, continues
throughout lactation, and declines sharply on the same day
that stromelysin-1 mRNA is maximally induced (Fig. 1 a;
Talhouk et al., 1992). Transgenic huTIMP-1 is expressed
in parallel with actin mRNA. TIMP-2 and -3 are expressed
throughout mammary development, decreasing during
lactation (Fig. 1 a).
 
TIMP-1 Overexpression and Stromelysin-1 Deficiency 
Do Not Affect Apoptosis or Loss of Mammary 
Epithelial Function during Mammary Gland Involution
 
To determine whether Str1 has a role in inducing epithe-
lial cell apoptosis during mammary gland involution after
weaning, we measured DNA laddering in tissue extracts
from wild-type, TO transgenic, and 
 
Str1
 
2
 
/
 
2
 
 mice. In wild-
type mice, ladders of DNA appeared between 1 and 3 d af-
ter weaning (Fig. 1, b and c), correlating with the appear-
ance of residual cell bodies in alveolar lumens in histologi-
cal samples (data not shown; also see Lund et al., 1996).
The peak of cell death was at 3 d, and cell death was signif-
icant for 8–10 d. After 10 d, resorption of the epithelium
(
 
.
 
90% of epithelial cells) was complete. DNA laddering
was also evident 2 and 3 d after the removal of pups (Fig. 1
c) from TO mice, indicating that the onset of epithelial in-
volution was normal. To measure the decline of differenti-
Figure 1. Apoptosis and epithelial function during gland involu-
tion in transgenic mice. (a) Total RNA was extracted from mam-
mary glands at various time points, separated by agarose gel elec-
trophoresis (10 mg/track), transferred to membranes, and probed
with Str1, TIMP-1, -2 (2 mRNA species), TIMP-3, vimentin
(Vim; an internal standard related to mesenchymal cell number),
or cytokeratin 18 (CK18; an internal standard related to epithe-
lial cell number) cDNAs. The ethidium bromide–stained 28S
rRNA band is also shown for comparison. V, virgin; dP, days
pregnant; dL, days lactating; di, days after weaning of pups. (b)
To measure the onset of programmed cell death, DNA was ex-
tracted from glands at various stages and analyzed by agarose gel
electrophoresis for evidence of laddering. Epithelial cells began
to die between 1 and 3 d after weaning of pups. 1L and 8L, 1 and
8 d lactation; 1i–20i: 1 – 20 d involution after removal of pups af-
ter 8 d of lactation. (c) DNA samples from key time points, 2 and
3 d after weaning, are shown for two each of TO and control
mice. The onset of apoptosis is normal in TO mice. (d) Differen-
tiated epithelial function was assayed by measuring the expres-
sion of mRNA for the milk protein WAP. RNA was extracted
from glands at various stages of involution (L, lactating; 1i–4i, 1–4 d
of involution after removal of pups after 8 d of lactation) from
TO and control mice, and from Str12/2 and Str11/1 mice, and
was analyzed by hybridizing Northern blots with a WAP cDNA
probe. Ethidium bromide–stained gel tracks before membrane
transfer are shown for comparison (18S rRNA). No significant
differences were observed in either transgenic line. 
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ated epithelial cell function that occurs during weaning, we
assayed the expression of the mRNA for the milk protein,
whey acidic protein (WAP). Surprisingly, both TO and
 
Str1
 
2
 
/
 
2
 
 mice showed the wild-type pattern of declining
expression between days 2 and 3 postweaning (Fig. 1 d).
These data indicate that Str1 and other TIMP-1–inhib-
itable MMPs do not play a significant role in apoptosis of
secretory epithelial cells. Why then is the expression of
Str1 so dramatically induced during mammary involution?
 
Mammary Adipogenesis Is Accelerated in Mice 
Deficient in MMP Function
 
We observed a striking alteration in the morphology of
MMP-deficient glands during involution (Fig. 2). At first
glance, these glands appeared to involute more rapidly be-
cause the area occupied by epithelial ducts and alveoli de-
creased. However, from morphological data, we deduced
that this was due to accelerated repopulation of the gland
with adipocytes. After weaning of wild-type mice allowed
to lactate for 8 d, there is a delay of 
 
z
 
4 d before significant
recolonization of the mammary gland with differentiated
adipocytes. In TO mice, differentiated hypertrophic adi-
pocytes appeared in greater number than wild type as
early as 2 d after weaning (Fig. 2, a and b). By histomor-
 
phometry of H&E-stained paraffin sections, mammary
glands of TO mice harvested 4 d after weaning contained
between 40 and 50% more unilocular adipocytes (Table I,
and Fig. 2, c and d).
Next we altered the time course of mammary involution
to determine whether this effect upon adipocyte differen-
tiation was maintained. When pups are removed after 2 in-
stead of 8 d of lactation, complete alveolar development is
prevented, the epithelium regresses more rapidly, and cell
death is complete by day 4 (Talhouk et al., 1992). Using
this protocol, we found that the process of adipocyte colo-
nization was accelerated in wild-type mice, so that the rel-
ative timing of adipocyte expansion and epithelial cell re-
gression is maintained (Fig. 2 e). When TO females were
weaned after 2 d of lactation, the differentiation of adipo-
cytes was increased relative to controls (Fig. 2 f).
Histomorphometric analysis of involuting glands from
 
Str1
 
2
 
/
 
2
 
 mice at 3 d (Fig. 2, g and h) and 6 d (Fig. 2, i and j)
after weaning revealed changes of adipocyte colonization
that resembled those seen in TO mice. Thus, the number of
adipocytes/microscopic field and the area that they occupied
increased by 30% 6 d after weaning 
 
Str1
 
2
 
/
 
2
 
 mice, and by
40% 4 d after weaning TO mice (Table I). Note that glands
are scored when adipocyte hypertrophy is maximal, and this
Figure 2. Inhibition of MMP activity affects the dy-
namics of the remodeling involuting mammary
gland. H&E-stained sections of wild type (a, c, and
e), TO (b, d, and f), Str1/1 (g and i), and Str12/2 (h
and j) at mammary glands at 8 d lactation and 2 d in-
volution (e and f), 8 d lactation and 4 d involution (c
and d), 2 d lactation and 3 d involution (e and f), 8 d
lactation and 3 d involution (g, h), and 8 d lactation
and 6 d involution (i and j). Glands deficient in MMP
activity show increased numbers of hypertrophic adi-
pocytes during mammary gland involution. 
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is different depending upon the mouse strain (TO mice and
 
Str1
 
2
 
/
 
2
 
 
 
mice are on CD1 and 129 strain backgrounds,
respectively). These data indicate that TIMP-1–sensitive
MMPs, including Str1, regulate mammary adipogenesis.
 
Str1 Upregulation Parallels Mammary Gland 
Adipogenesis, Angiogenesis, and Remodeling of Stromal 
Matrix during Involution
 
Why does the absence of Str1 affect the rate of adipocyte
differentiation? Previous studies using in situ
 
 
 
hybridiza-
 
tion have shown that Str1 mRNA is expressed by fibro-
blastic cells, some of which may be preadipocytes (Lund et
al., 1996). Str1 protein is frequently associated with blood
vessels (Talhouk et al., 1992). Detailed analysis of the time
course of expression of 
 
Str1
 
 mRNA, compared with other
markers of cell function (such as WAP mRNA expression)
showed that 
 
Str1
 
 was induced only after the loss of differ-
entiated epithelial cell function, and after the majority of
epithelial cell death. Notably, 
 
Str1
 
 was induced in parallel
with markers usually associated with active remodeling
and morphogenesis (Fig. 3).
Repopulation of the mammary gland by differentiated
adipocytes requires replacement of the interstitial ECM
around the fibroblast-like preadipocytes, which is rich in
fibrillar collagens and fibronectin (data not shown), by the
basement membranes that surround differentiated adipo-
cytes (Smas and Sul, 1995). Concomitantly, the vasculature
of the fat pad is remodeled so that there is a dense weave of
capillaries in intimate contact with adipocytes (Crandall et
al., 1997). mRNA for nidogen-1/entactin, an ECM molecule
that is a prominent component of adipocyte basement mem-
branes (see Fig. 4), was induced at 3 d, at the same time as
Str1 (Fig. 3, a and b). We observed that the expression of
PECAM-1 mRNA, a cell adhesion molecule specific to en-
dothelial cells, was induced at 3 d, and peaked at 6 d after
weaning. Interestingly, PECAM-1 mRNA was expressed at
a higher level in involuting glands from 
 
Str1
 
2
 
/
 
2
 
 mice (Table
I). These data lead us to conclude that the timing of induc-
tion of Str1 mRNA is consistent with its expression during
angiogenesis and remodeling by the stromal compartment.
 
Mammary Gland Involution Is Characterized by a 
Biosynthetic Phase
 
We next verified that there was a switch in ECM at this
time in involution. The activation of a biosynthetic stromal
compartment was reflected in changes in the ECM of invo-
luting glands. We observed dramatic changes in the protein
profiles by SDS-PAGE analysis of ECM-enriched extracts
in response to weaning. At 1 d after weaning, the mammary
gland extracts contained collagens (Fig. 3 b, arrowheads),
entactin, and laminin. These protein profiles resembled ex-
tracts from pregnant and lactating glands (Alexander et al.,
1996; and data not shown). Coincident with the induction
of epithelial apoptosis at 2 d after weaning, most basement
 
Table I. Altered Adipogenesis and PECAM Expression in Involuting Glands of Str1
 
2
 
/
 
2
 
 and TO Mice
 
Mouse strain
Alveolar 
density
Adipocytes 
No./field
Adipocytes 
area/field
PECAM-1 
mRNA/actin 
mRNA
 
Pixels %
 
Str1
 
1
 
/
 
1
 
9890 
 
6 
 
604 650 
 
6 
 
39 72 0.65 
 
6 
 
0.06
Str1
 
2
 
/
 
2
 
6824 
 
6 
 
550 842 
 
6 
 
55 91 0.95 
 
6 
 
0.04
Percent 
 
Str1
 
2
 
/
 
2 
 
/ Str1
 
1
 
/
 
1 69 6 8 129 6 7 126 6 2.2 150 6 4
Control 15980 6 785 310 6 21 56 6 4N D
TO 10120 6 802 420 6 29 79 6 7N D
Percent TO/control 63 6 8 145 6 7 141 6 8N D
To quantitate histomorphometric changes, representative frames (four frames from each of three mice, n 5 12) of H&E-stained sections from Str11/1 and 2/2 mice 6 d after
weaning, and from TO and control mice 4 d after weaning (Fig. 2), were analyzed by measuring average pixel density using Adobe Photoshop software. Adipocytes do not stain
with H&E, so dark pixels derive from epithelial components. An increase in the number of differentiated adipocytes is revealed as a decrease in average pixel density. The number
of unilocular adipocytes per field was counted manually, and the area occupied by these cells was determined by tracing frames onto paper and excising areas occupied by epithe-
lia. These two measurements show a reproducible 30 and 40% increase (Str12/2 and TO mice, respectively) in adipocyte colonization. Finally, to measure the angiogenesis that
occurs during fat pad reexpansion, PECAM-1 mRNA expression (an endothelial marker) was quantitated by scanning slot blots of RNA extracted at 6 d after weaning from Str12/2
and 1/1 mice (n 5 3 for each sample type). Actin mRNA expression was used to normalize the amount of PECAM-1 from sample to sample. The amount of PECAM-1 mRNA
was increased by 50% in the MMP-deficient mice.
Figure 3. Upregulation of
Str1 mRNA expression dur-
ing stromal remodeling of in-
voluting mammary gland. (a)
mRNA was extracted from
mammary glands at various
time points (L, lactating; 1i–
10i, 1–10 d of involution after
weaning pups), Northern
blots were prepared and
probed with cDNAs encod-
ing the milk protein WAP,
Str1, the basement mem-
brane protein entactin, and
the endothelial cell surface
adhesion molecule PECAM-1.
(b) ECM-enriched extracts
of 8 mg of mammary tissue
from control and TO mice
1–4 d after weaning (1i–4i)
were analyzed by SDS-
PAGE; gels were either Coo-
massie blue stained (CB) or
transferred to membranes
for incubation with antisera
to either entactin or laminin.
Molecular weights of pro-
teins are indicated at the left-
hand side. Entactin migrates at 150 kD, with specific MMP-
derived cleavage fragments migrating at 100 and 110 kD. The
ECM-enriched fraction changes dramatically during the involu-
tive phase of mammary gland remodeling (2–4 d after weaning).
The collagens (arrowheads) and basement membrane proteins
(entactin and laminin) are substantially reduced.The Journal of Cell Biology, Volume 152, 2001 698
membrane proteins, including basement membranes entac-
tin and laminin, disappeared from the ECM-enriched frac-
tion (Fig. 3 b). Immunoreactive entactin and laminin began
to reappear after 3 d of involution (Fig. 3 b), when their
mRNA transcripts were upregulated (Fig. 3 a, and data not
shown) and were present in high amounts after 4 d.
To better define the cellular events that lead to these
striking changes, we stained sections of involuting gland
with antibodies to basement membrane proteins. Surpris-
ingly, 2 and 3 d after weaning, the amount of entactin in
basement membranes around epithelial alveoli appeared
similar to that during lactation (Figs. 3 and 4). We con-
clude that during the initiation phase of apoptosis in invo-
luting gland, ECM proteins normally SDS soluble become
insoluble, leaving their antigenicity unaffected and the
morphology of the basement membranes (at the light mi-
croscopic level) unchanged. We suggest that these bio-
chemical changes are the result of extracellular cross link-
ing by tissue transglutaminase, an enzyme known to be
induced during apoptosis of other cell types (see Discus-
sion). The increase of entactin protein measured biochem-
ically by SDS-PAGE analysis of glands 4 d after weaning
(Fig. 3) paralleled the increase of entactin observed by im-
munostaining around hypertrophying adipocytes in sec-
tions of similar glands (Fig. 4, 4i). During the biosynthetic
phase (arrows), entactin protein localized not only to the
regressing, insoluble epithelial basement membranes, but
to the assembling, soluble basement membranes that sur-
round hypertrophying adipocytes.
We then sought evidence to verify that the upregulation
of Str1 had functional consequences by examining the in-
tegrity of one of its substrates in vivo, entactin/nidogen-1.
The coinduction of Str1 and entactin during the biosyn-
thetic phase of involution led to a characteristic pattern of
entactin fragmentation (Fig. 3 b, Entactin), the result of
Str1 cleavage of the 150-kD entactin molecule between
the G1 and G2 domains (Alexander et al., 1996). This pro-
teolysis was almost completely inhibited in parallel sam-
ples from TO mice. This result shows that the TIMP-1
transgene was not only highly expressed during involution,
but that it was also an effective MMP inhibitor.
MMPs Regulate Adipogenesis in 3T3-L1 Cells
in Culture
The results of the genetic experiments in the mice de-
scribed above suggest that the rate of adipocyte hypertro-
phy in the mammary gland is enhanced in the absence of
Str1. However, adipogenesis could be either a direct or an
indirect target of MMPs in vivo. To examine whether
there are direct effects of MMPs, we used a model system
of adipogenic differentiation, namely cultured 3T3-L1
cells. These fibroblastic cells are not adipogenic in subcon-
fluent cultures. At confluence, the cells become commit-
ted preadipocytes. Treatment of confluent cultures with a
differentiation-inducing mix (DM; dexamethasone, insu-
lin, and methylisobutylxanthine) induces the expression of
proteins associated with mature adipocytes and the accu-
mulation of lipids (Bernlohr et al., 1984).
We first determined the expression of MMPs and
TIMPs in 3T3-L1 cells. Str1 expression was developmen-
tally regulated in differentiating 3T3-L1 cells. Str1 mRNA
was highly induced in confluent, committed preadipocytes,
and expression continued in differentiating cultures (Fig. 5
a). We used the expression of two transcription factors
that are expressed by differentiated adipocytes (peroxi-
some proliferator-activated receptor-g (pPARg) mRNA,
a nuclear hormone receptor, and C/EBPb) to monitor the
differentiation reaction. Thus, C/EBPb was highly induced
after 2 d of treatment with DM (Fig. 6 a), and pPARg af-
ter 4 d (Fig. 5 a) in parallel with lipid accumulation (Fig. 6,
b and c). Since Str1 can activate other MMPs, leading to a
cascade of MMP-dependent proteolysis, we determined
the expression of other MMPs. mRNA for collagenase-3
(MMP-13) was induced in parallel with Str1. mRNA for
the cell-surface bound MT1-MMP (MMP-14), was also in-
duced in committed cells, and increased during differentia-
tion. mRNA for matrilysin (MMP-7) and collagenase
(MMP-1) were not detected (data not shown).
The expression of the proteolytic activity of MMPs is
regulated by TIMPs. All four TIMPs were expressed in ad-
ipocytes, as they are in vivo in the mammary fat pat of mice
during puberty (Fata et al., 1999). TIMP-1 and -3 were
highly induced in committed cells, but showed little expres-
sion in differentiated adipocytes. TIMP-4 was expressed
specifically by differentiated adipocytes, increasing in par-
allel with pPARg. TIMP-2 expression was characteristic of
committed and differentiated cells. We conclude that dif-
ferentiated cells express a higher ratio of mRNAs for
MMPs compared with TIMPs than committed cells.
We found that the relative increase in MMP mRNA ex-
pression was accompanied by an induction of proteolytic
activity specific to the differentiation phase of 3T3-L1 de-
velopment. Gelatinase A (MMP-2) was the major MMP
identified by zymography of enzymes secreted into the
Figure 4. Immunostaining of
entactin shows that epithelial
basement membranes are re-
tained during involution.
Fixed cryosections from nor-
mal glands 1–4 d after wean-
ing were stained for entac-
tin. During gland involution
(1i–4i), basement mem-
branes around epithelial al-
veoli stained positively for
entactin (brown HRP-linked
product; arrowheads). 4 d after weaning (4i), entactin also appears around hypertrophying adipocytes (arrows). Immunostaining exper-
iments using a subsaturating, diluted primary antibody (1:2,000), aimed at ensuring that this assay was quantitative for glands 2–3 d after
weaning, did not show the dramatic loss of entactin observed biochemically (Fig. 3). Control sections (incubated with rat antiserum in
place of primary antibody) are blank except for methylene blue–stained nuclei (c).Alexander et al. Stromelysin-1 Regulates Adipogenesis 699
media of induced 3T3-L1 cells (Fig. 5 b). MT1-MMP acti-
vates gelatinase A in a TIMP-2–dependent fashion (Will
et al., 1996; Holmbeck et al., 1999; Caterina et al., 2000;
Wang et al., 2000; Zhou et al., 2000). We observed signifi-
cant activation of gelatinase A after 4 d of differentiation,
and further induction and activation after 8 d. Thus, as in-
hibitor expression declined and MT1-MMP expression in-
creased during adipocyte differentiation, this proteinase
was activated.
In vivo, we found that ectopic expression of TIMP-1 ex-
pression increased the rate of adipocyte differentiation. If
this effect is mediated by a direct effect on adipocytes, we
would expect that the addition of an MMP inhibitor would
increase the rate of adipogenesis during the differentiation
of adipocytes in vitro. To test this hypothesis, we added
three different MMP inhibitors [a synthetic hydroxamate
inhibitor (GM6001; 10 mM), recombinant human TIMP-1
(250 nM), or natural human TIMP-1 purified from trans-
fected BHK cells (250 nM)] to cultures of committed 3T3-
L1 cells concomitant with the differentiation-inducing mix.
An accelerated rate of differentiation with increased C/EBPb
expression was evident at day one of differentiation (Fig. 6
a). All three inhibitors stimulated lipogenesis by cells 4 d
after induction by more than sevenfold (Fig. 6, b and c).
We conclude that Str1 determines the rate of hypertrophy
and lipogenesis in differentiating adipocytes and that, in its
absence, differentiation is accelerated.
Discussion
Stromelysin-1 Does Not Regulate Mammary Epithelial 
Cell Death during Involution Caused by Weaning
Basement membranes control the morphogenesis and sur-
vival of epithelial cells (Weaver and Bissell, 1999) and are
continuously remodeled by processes that are poorly under-
stood. For example, the amount of specific basement mem-
brane proteins is cyclically regulated during the division and
death of mammary epithelium typical of human breast
(Ferguson et al., 1992). By using two strains of transgenic
mice with low endogenous MMP activity, we tested whether
MMPs induced during involution contribute to the process.
Our data indicate that Str1 regulates the phenotypic expres-
sion of stromal cells rather than mammary epithelial apop-
tosis during mammary gland involution. It is evident from
earlier studies that overexpression of Str1 induces an al-
tered stromal phenotype, with increases in collagen deposi-
tion during pregnancy (Thomasset et al., 1998). However,
two lines of evidence from previous work implicated MMPs
in mammary epithelial cell death during weaning. First, El-
vax pellets containing TIMP-1, implanted at the onset of in-
volution, protect proximal epithelial cells from death (Tal-
houk et al., 1992). Second, ectopic Str1 induces unscheduled
Figure 6. Inhibition of MMP activity accelerates lipogenesis in
3T3-L1 cultures. Confluent cultures of 3T3-L1 cells were induced
to differentiate by adding DM, either in the presence or absence
of the hydroxamate inhibitor GM6001, recombinant human
TIMP-1 (rhTIMP1), or purified human TIMP-1 (hTIMP1). (a) In
the presence of GM6001, nuclear C/EBPb protein appears just 24 h
after DM administration, earlier than control cultures. (b) After
4 d, the accumulation of lipid was assessed by Oil red O staining
of tissue culture dishes containing 3T3-L1 cells. (c) To quantify
Oil red O staining, the cultures were extracted in propanol and
the absorbance at 510 nm was measured. Control cultures (con)
were untreated with DM. Results shown are the average of six
determinations and the bars indicate standard deviations. Cells
treated with DM alone were normalized to one to reveal the fold
induction of lipogenesis in the presence of MMP inhibitors. P val-
ues were determined using the Student’s t test.
Figure 5. Expression of
MMPs and TIMPs during
adipocyte differentiation.
(a) RNA was extracted
from cultures of 3T3-L1
cells at various stages of dif-
ferentiation. pre, subconflu-
ent fibroblastic precursor;
com, confluent, committed
stage at day 0 of differentia-
tion; 2–8 dD, 2–8 d differen-
tiation after administration
of DM. RNA was separated
by agarose gel electro-
phoresis and transferred to
membranes for analysis of
expression of specific MMP
and inhibitor mRNAs. Au-
toradiograms were scanned
and the relative expression
of specific mRNAs is a ratio
of EtBr-stained 18S rRNA
was quantified. (b) En-
zymes secreted by adipo-
cytes into supernatant me-
dia were analyzed by
gelatin zymography. Gelati-
nase A, identified by comparison with mouse enzyme stan-
dards, was progressively upregulated and activated (*) as 3T3-
L1 cells differentiated.The Journal of Cell Biology, Volume 152, 2001 700
programmed cell death during late pregnancy in transgenic
mice and also induces death in vitro in cultured mammary
epithelial cells (Sympson et al., 1994; Boudreau et al., 1995).
An identical phenotype is induced by inhibitors of b1 inte-
grin, suggesting that Str1 and b1 integrin operate in the
same pathway to induce cell death, and that Str1 cleaves a
b1 integrin ligand (Boudreau et al., 1995, 1996; Faraldo et
al., 1998; Klinowska et al., 1999).
In fact, Str1 is not induced early enough to be the natu-
ral initiator of cell death. It appears later during the bio-
synthetic wave. It is not surprising, therefore, that epithe-
lial apoptosis was unaffected in Str12/2 mice. However,
the lack of effect in TO mice suggests that other TIMP-
1–sensitive MMPs are not implicated either. One hypothe-
sis that could reconcile the inhibition of mammary epithe-
lial cell death caused by implants of TIMP-1 (Talhouk et
al., 1992) with the lack of inhibition observed in this ge-
netic analysis of TO and Str12/2 mice is that inflamma-
tory cytokines, induced by surgery, are known to protect
mammary epithelial cells from cell death (Lund et al.,
1996). Another explanation could be that the TIMP-1 con-
centration was likely much higher in the affected zone
proximal to the implanted pellets containing 10 mg of
TIMP-1 (as high as 1–5 mM). In TO mice, concentrations
of TIMP-1 were 0.1–2 nM in plasma and tissues (30 ng/ml
tissue lysate of mammary gland 1 d after weaning; Alex-
ander et al., 1996), sufficient to inhibit entactin proteolysis.
For full efficacy, TIMP-1 was added to 3T3-L1 cell cul-
tures at 250 nM, and the peptide hydroxamate GM 6001
inhibitor at 10 mM. At these levels, MTI-MMP and other
metalloproteinases, such as ADAM-TS aggrecanase-1
(Arner et al., 1999), or other ADAMs might be inhibited.
These enzymes are responsible for cleavage and shedding
of many cell-surface proteins that regulate cell function
and death (Amour et al., 1998).
Mice with null mutations other than MMPs have been
tested for defects of involutive processes: uterine involu-
tion is normal in mice with a null mutation in matrilysin/
MMP-7, possibly due to compensatory expression of other
MMPs (Rudolph-Owen et al., 1997). On the other hand,
apoptosis of chondrocytes during the ossification of
growth plates in juvenile bone is inhibited by the absence
of gelatinase-B/MMP-9 (Vu et al., 1998). This effect is not
mediated by cleavage of ECM components but instead by
reduced bioavailability of the growth factor, VEGF (Ger-
ber et al., 1999). If MMPs do not mediate epithelial cell ap-
optosis during mammary gland involution, are proteinases
required at all? Certainly, mice lacking the serine protein-
ase plasminogen show reduced apoptosis during mam-
mary involution (Lund et al., 2000). Interestingly, in con-
trast to MMPs, the serine proteinases positively regulate
adipogenesis (Selvarajan et al., 2001).
Stromelysin-1 Expression Occurs during a Biosynthetic 
Wave that Remodels the Mammary Gland 
during Involution
Using light microscopy and immunohistochemistry, we
found no substantial change in amount, distribution, or ap-
pearance of specific components of the epithelial basement
membranes during early involution. However, biochemi-
cally, the properties of these basement membrane proteins is
dramatically affected between 1 and 2 d after weaning. Most
become detergent insoluble and disappear from protein pro-
files of gland extracts. Soluble ECM components are almost
completely absent during the onset of apoptosis. Using high-
resolution techniques, some investigators have reported the
apparent thickening of basement membranes during this
phase (Strange et al., 1992; Warburton et al., 1982).
The induction of the enzyme tissue transglutaminase
may explain these alterations of basement membrane
morphology and biochemistry. This enzyme is associated
with the onset of apoptosis in a number of cell types
(Melino and Piacentini, 1998), and is induced in early in-
voluting mammary gland (Strange et al., 1992; Guenette et
al., 1994). By cross linking many extracellular proteins, in-
cluding basement membrane proteins such as laminin, col-
lagen IV, and entactin, this enzyme is likely to be responsi-
ble for the biochemical alterations we observed in the
ECM fractions at the onset of apoptosis. The stimulus for
mammary involution clearly involves withdrawal of lacto-
genic hormones, and may include local stimuli such as milk
edema (Lascelles and Lee, 1978; Tenniswood et al., 1992).
The histological data, together with the transcriptional
activation of gene products typically associated with bio-
synthesis, describe an anabolic process that follows, and is
closely coordinated with, the catabolic loss of epithelial cell
function (Fig. 7). Taking advantage of the ability to manip-
ulate the absolute timing of epithelial involution by alter-
Figure 7. Mammary involu-
tion is divided into two inter-
active phases for epithelial
and stromal remodeling. This
scheme summarizes the rela-
tive time course of the cata-
bolic events associated with
epithelial involution, namely
the loss of milk protein syn-
thesis (differentiated func-
tion), together with apopto-
sis and regression of the
majority of the epithelial
cells, and the anabolic events
responsible for reexpanding
the fat pad.Alexander et al. Stromelysin-1 Regulates Adipogenesis 701
ing the number of pups suckled and the length of lactation,
we observed that the biosynthetic phase begins when WAP
expression is reduced to ,10% lactating levels and the
number of live differentiated epithelial cells is reduced by
50%. During late pregnancy and immediately after parturi-
tion, the number of differentiated adipocytes in the fat pad
(depending upon the mouse strain) is reduced to almost
zero, and the majority of the gland becomes epithelial
(Elias et al., 1972). Differentiated adipocytes collapse, but
persist as thin, elongated undifferentiated cells during lac-
tation (Ailhaud et al., 1992; Neville et al., 1998), which re-
semble the mammary fibroblasts surrounding the ductal
network in the resting gland (Cunha and Hom, 1996). Dur-
ing involution, adipocytes recolonize the interalveolar
spaces, differentiate, and accumulate lipid until a fat pad of
approximately virgin size is reconstituted. Clearly, adipo-
cytes and epithelial cells interact to maintain a relative bal-
ance of these two cell types in the gland. Although several
growth and transcription factors affect apoptosis or sur-
vival in mammary glands (Furth, 1999; Song et al., 2000),
the specific factors involved in local reciprocal control of
adipocyte and epithelial involution are not yet understood.
Stromelysin-1 Accelerates Adipocyte Differentiation 
both in a Culture Model and In Vivo during Fat 
Pad Expansion
Str12/2 and TO mice showed unusual patterns of adipo-
cyte colonization in involuting glands. Although the acti-
vation of the biosynthetic phase is not changed in these
mice, the differentiation and hypertrophy of adipocytes is
enhanced by 30–40% during active recolonization. Since
Str1 mRNA is highly induced during fat cell differentia-
tion, and fat cell differentiation is accelerated in glands
with a null mutation, we hypothesize that Str1 normally in-
hibits adipocyte lipogenesis.
In support of this notion, the addition of MMP inhibitors
to a culture model of differentiating adipocytes (3T3-L1
cells) accelerated lipogenesis sevenfold. 3T3-L1 cells were
originally isolated as a lipogenic substrain of 3T3 fibroblasts
(Green and Meuth, 1974), and have been validated as a
model of adipogenesis (Cornelius et al., 1994). Confluent
precursor cells express markers specific to pre-adipocytes.
After stimulation with inducers of cAMP accumulation,
cells accumulate triglycerides, express many markers of ter-
minal differentiation, and resemble multilocular adipocytes.
Our data analyzing expression of an array of MMPs and
their inhibitors suggest that high expression of Str-1, colla-
genase-3 (MMP-13), and MT-1 (MMP-14), and of the in-
hibitors TIMP-1, -2, and -3, parallel the commitment of un-
differentiated 3T3-L1 fibroblast precursors to the adipocyte
lineage. This coinduction of enzymes and inhibitors gener-
ates a low proteolytic index (proteinases/inhibitors), associ-
ated with the appearance of secreted latent gelatinase A
(MMP-2). Other groups have shown that the amount of
MMP-2 increases and TIMP-1 decreases during adipocyte
differentiation (Johnson et al., 1994; Brown et al., 1997). An
increase in the proteolytic index accompanies the transition
from preadipocyte to terminally differentiated fat cells in
culture. Specifically, the expression of mRNA for all three
enzymes continues at high level, whereas that for TIMP-1
and -3 decreases. Concomitant with these changes, active
MMP-2 appears in the medium. The expression of TIMP-2
mRNA is unaffected by differentiation. This inhibitor has a
dual regulatory function for MMP-2, catalyzing the forma-
tion of a ternary activating complex for MT1 MMP at the
cell surface, and inhibiting soluble enzyme activity (Gomez
et al., 1997). TIMP-3 is an ECM-bound inhibitor that has a
highly distinct inhibitor profile, inhibiting TACE and other
membrane-bound disintegrin metalloproteinases (Amour
et al., 1998). Interestingly, we found that TIMP-4 (Gomez
et al., 1997) is induced in parallel with classic markers of ter-
minal differentiation (Ailhaud et al., 1992), such as pPARg.
TIMP-4 may be the endogenous mediator that promotes
terminal differentiation in adipocytes and may be a useful,
novel adipocyte marker. By adding MMP inhibitors to
maintain a low proteolytic index experimentally during the
onset of differentiation in these cultures, lipogenesis is strik-
ingly accelerated, mimicking the result observed in vivo.
There are several plausible mechanisms by which inhibi-
tion of MMPs could accelerate adipogenesis. The bioavail-
ability of positive differentiation factors, such as IGF-1/
IGF–binding protein (Rajkumar et al., 1999), and negative
differentiation factors, such as Wnts (Cunha and Hom,
1996; Ross et al., 2000), may be regulated by MMP action.
Alternatively, MMPs may regulate the assembly of base-
ment membrane per se. We favor the latter mechanism be-
cause adipocyte differentiation is characterized by the dra-
matic upregulation of synthesis of basement membrane
proteins (Aratani and Kitagawa, 1988). Accumulation of
basement membrane distinguishes the adipocyte from its
mesenchymal precursor, and may initiate terminal differ-
entiation by stabilizing the adipocyte cell surface and gen-
erating specific intracellular signals. In support of this,
Kawaguchi et al. (1998) found that subcutaneous injection
of basement membrane (together with bFGF) induced the
formation of stable fat pads in mice. Assembly of ECM is
likely to be rate limiting for the differentiation of these
cells; therefore, by coexpressing Str1 during differentia-
tion, adipocytes may limit their own development. Indeed,
Str1 cleaves entactin/nidogen-1 in vivo (Alexander et al.,
1996), and entactin fragments inhibit the rate of basement
membrane assembly (Pujuguet et al., 2000). Using primary
rat adipocytes, Brown et al. (1997) found that the accumu-
lation of ECM by differentiating clusters of cells was facili-
tated by the zinc chelator, 1,10-phenanthroline. In the
present study, we observed that, under conditions inhibit-
ing MMP function, entactin fragmentation ceases and adi-
pocyte differentiation increases.
If MMPs are important in adipogenesis, then Str12/2
and TO mice could show increased adipogenesis in other
tissues. MMPs may be rate limiting for differentiation only
under situations where adipogenesis is very rapid, as it is
during mammary involution. Fat pads from Str12/2 fe-
males on a 129 background were normal. However, the
Str12/2 mice backcrossed onto an FVB/N background
become obese with increasing age, reaching weights of up
to 60 g (our unpublished observations). It may be relevant
that humans with an allele that decreases Str1 promoter
function to 25–50% show accelerated progression of their
atherosclerotic lesions (Ye et al., 1996).
In conclusion, we have revealed a novel physiological
role for MMPs as negative regulators of adipocyte metab-
olism and differentiation. The mechanisms by which epi-
thelial death and basement membrane remodeling are reg-
ulated still remain elusive.The Journal of Cell Biology, Volume 152, 2001 702
We are grateful to Dr. Rabih Talhouk for performing the Str1 Northern
blot. We thank Dr. Lisa Coussens for bringing to our attention the obesity
in FVB/N-Str12/2 mice. 
This work was supported by grants from the National Cancer Institute
(CA 57621 and CA 72006 to Z. Werb) and an Arthritis Foundation Inves-
tigator award (to C.M. Alexander).
Submitted: 31 October 2000
Revised: 26 December 2000
Accepted: 28 December 2000
References
Ailhaud, G., P. Grimaldi, and R. Negrel. 1992. Cellular and molecular aspects
of adipose tissue development. Annu. Rev. Nutr. 12:207–233.
Alexander, C.M., E.W. Howard, M.J. Bissell, and Z. Werb. 1996. Rescue of
mammary epithelial cell apoptosis and entactin degradation by a TIMP-1
transgene. J. Cell Biol. 135:1669–1677.
Amour, A., P.M. Slocombe, A. Webster, M. Butler, C.G. Knight, B.J. Smith,
P.E. Stephens, C. Shelley, M. Hutton, V. Knauper, A.J. Docherty, and G.
Murphy. 1998. TNF-a converting enzyme (TACE) is inhibited by TIMP-3.
FEBS Lett. 435:39–44.
Aratani, Y., and Y. Kitagawa. 1988. Enhanced synthesis and secretion of type
IV collagen and entactin during adipose conversion of 3T3-L1 cells and pro-
duction of unorthodox laminin complex. J. Biol. Chem. 263:16163–16169.
Arner, E.C., M.A. Pratta, J.M. Trzaskos, C.P. Decicco, and M.D. Tortorella.
1999. Generation and characterization of aggrecanase. A soluble cartilage-
derived aggrecan-degrading activity. J. Biol. Chem. 274:6594–6601.
Bernlohr, D.A., C.W. Angus, M.D. Lane, M.A. Bolanowski, and T.J. Kelly.
1984. Expression of specific mRNAs during adipocyte differentiation: identi-
fication of an mRNA encoding a homologue of myelin P2 protein. Proc.
Natl. Acad. Sci. USA. 81:5468–5472.
Boudreau, N., C.J. Sympson, Z. Werb, and M.J. Bissell. 1995. Suppression of
ICE and apoptosis in mammary epithelial cells by extracellular matrix. Sci-
ence. 267:891–893.
Boudreau, N., Z. Werb, and M.J. Bissell. 1996. Suppression of apoptosis by
basement membrane requires three-dimensional tissue organization and
withdrawal from the cell cycle. Proc. Natl. Acad. Sci. USA. 93:3509–3513.
Brown, L.M., H.L. Fox, S.A. Hazen, K.F. LaNoue, S.R. Rannels, and C.J.
Lynch. 1997. Role of the matrixin MMP-2 in multicellular organization of
adipocytes cultured in basement membrane components. Am. J. Pathol. 272:
C937–C949.
Capetanaki, Y., I. Kuisk, K. Rothblum, and S. Starnes. 1990. Mouse vimentin:
structural relationship to fos, jun, CREB and tpr. Oncogene. 5:645–654.
Caterina, J.J., S. Yamada, N.C. Caterina, G. Longenecker, K. Holmback, J. Shi,
A.E. Yermovsky, J.A. Engler, and H. Birkedal-Hansen. 2000. Inactivating
mutation of the mouse tissue inhibitor of metalloproteinases-2 (Timp-2)
gene alters ProMMP-2 activation. J. Biol. Chem. 275:26416–26422.
Cornelius, P., O.A. MacDougald, and M.D. Lane. 1994. Regulation of adipo-
cyte development. Annu. Rev. Nutr. 14:99–129.
Crandall, D.L., G.J. Hausmann, and J.G. Kral. 1997. A review of the microcir-
culation of adipose tissue: anatomic, metabolic and angiogenic perspectives.
Microcirculation. 4:211–232.
Cunha, G.R., and Y.K. Hom. 1996. Role of mesenchymal-epithelial interactions
in mammary gland development. J. Mammary Gland Biol. Neoplasia. 1:21–
35.
Elias, J.J., D.R. Pitelka, and R.C. Armstrong. 1972. Changes in fat cell mor-
phology during lactation in the mouse. Anat. Rec. 177:533–548.
Faraldo, M.M., M.-A. Deugnier, M. Lukashev, J.P. Thiery, and M.A.
Glukhova. 1998. Perturbation of b1-integrin function alters the development
of murine mammary gland. EMBO (Eur. Mol. Biol. Organ.) J. 17:2139–2147.
Fata, J.E., K.J. Leco, R.A. Moorehead, D.C. Martin, and R. Khokha. 1999.
Timp-1 is important for epithelial proliferation and branching morphogene-
sis during mouse mammary development. Dev. Biol. 211:238–254.
Ferguson, J.E., A.M. Schor, A. Howell, and M.W.J. Ferguson. 1992. Changes in
the extracellular matrix of the normal human breast during the menstrual cy-
cle. Cell Tissue Res. 268:167–177.
Finbloom, D.S., E.F. Petricoin III, R.H. Hackett, M. David, G.M. Feldman, K.
Igarashi, E. Fibach, M.J. Weber, M.O. Thorner, C.M. Silva, et al. 1994.
Growth hormone and erythropoietin differentially activate DNA-binding
proteins by tyrosine phosphorylation. Mol. Cell. Biol. 14:2113–2118.
Furth, P.A. 1999. Mammary gland involution and apoptosis of mammary epi-
thelial cells. J. Mammary Gland Biol. Neoplasia. 4:123–127.
Gerber, H.-P., T.H. Vu, A.M. Ryan, J. Kowalski, Z. Werb, and N. Ferrara.
1999. VEGF couples hypertrophic cartilage remodeling, ossification and an-
giogenesis during endochondral bone formation. Nat. Med. 5:623–628.
Gewert, D.R., B. Coulombe, M. Castelino, D. Skup, and B.R.G. Williams. 1987.
Characterization and expression of a murine gene homologous to human
EPA/TIMP: a virus-induced gene in the mouse. EMBO (Eur. Mol. Biol. Or-
gan.) J. 6:651–657.
Gomez, D.E., D.F. Alonso, H. Yoshiji, and U.P. Thorgeirsson. 1997. TIMPs:
structure, regulation and biological functions. Eur. J. Cell Biol. 74:111–122.
Green, H., and M. Meuth. 1974. An established pre-adipocyte cell line and its
differentiation in culture. Cell. 3:127–133.
Gross, J. 1966. How tadpoles lose their tails. J. Invest. Derm. 47:274–277.
Guenette, R.S., H.B. Corbeil, J. Leger, K. Wong, V. Mezl, M. Mooibroek, and
M. Tenniswood. 1994. Induction of gene expression during involution of the
lactating mammary gland of the rat. J. Mol. Endocrinol. 12:47–60.
Holmbeck, K., P. Bianco, J. Caterina, S. Yamada, M. Kromer, S.A. Kuznetsov,
M. Mankani, P.G. Robey, A.R. Poole, I. Pidoux, et al. 1999. MT1-MMP–
deficient mice develop dwarfism, osteopenia, arthritis, connective tissue dis-
ease due to inadequate collagen turnover. Cell. 99:81–92.
Jerry, D.J., C. Kuperwasser, S.R. Downing, J. Pinkus, C. He, E. Dickinson, S.
Marconi, and S.P. Naber. 1998. Delayed involution of the mammary epithe-
lium in BALB/c-p53 null mice. Oncogene. 17:2305–2312.
Johnson, M.D., H.R. Kim, L. Chesler, G. Tsao-Wu, N. Bouck, and P.J. Polver-
ini. 1994. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase.
J. Cell Physiol. 160:194–202.
Kawaguchi, N., K. Toriyama, E. Nicodemou-Lena, K. Inou, S. Torii, and Y.
Kitagawa. 1998. De novo adipogenesis in mice at the site of injection of base-
ment membrane and basic fibroblast growth factor. Proc. Natl. Acad. Sci.
USA. 95:1062–1066.
Kulesh, D.A., and R.G. Oshima. 1988. Cloning of the human keratin 18 gene
and its expression in nonepithelial mouse cells. Mol. Cell. Biol. 8:1540–1550.
Klinowska, T.C., J.V. Soriano, G.M. Edwards, J.M. Oliver, A.J. Valentijn, R.
Montesano, and C.H. Streuli. 1999. Laminin and b1 integrins are crucial for
normal mammary gland development in the mouse. Dev. Biol. 215:13–32.
Lascelles, A.K., and C.S. Lee. 1978. Involution of the mammary gland. In Lac-
tation: A Comprehensive Treatise. Volume 4. B.L. Larson and V.R. Smith,
editors. Academic Press, Inc., New York, NY. 115–177.
Leco, K.J., S.S. Apte, G.T. Taniguchi, S.P. Hawkes, R. Khokha, G.A. Schultz,
and D.A. Edwards. 1997. Murine tissue inhibitor of metalloproteinase-4
(TIMP-4): cDNA isolation and expression in adult mouse tissues. FEBS
Lett. 401:213–217.
Leco, K.J., R. Khokha, N. Pavloff, S.P. Hawkes, and D.R. Edwards. 1994. Tis-
sue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-
associated protein with a distinctive pattern of expression in mouse cells and
tissues. J. Biol. Chem. 269:9352–9360.
Li, M., J. Hu, K. Heermeier, L. Hennighausen, and P.A. Furth. 1996. Apoptosis
and remodeling of mammary gland tissue during involution proceeds
through p53-independent pathways. Cell Growth Differ. 7:13–20.
Li, F., R. Strange, R.R. Friis, V. Djonov, H.-J. Altermatt, S. Saurer, H. Nie-
mann, and A.-C. Andres. 1994. Expression of stromelysin-1 and TIMP-1 in
the involuting mammary gland and in early invasive tumors of the mouse.
Int. J. Cancer. 59:560–568.
Lochter, A., S. Galosy, J. Muschler, N. Freedman, Z. Werb, and M.J. Bissell.
1997. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular
alterations that leads to stable epithelial-to-mesenchymal conversion and a
premalignant phenotype in mammary epithelial cells. J. Cell Biol. 1139:
1861–1872.
Lund, L.R., S.F. Bjørn, M.D. Sternlicht, B.S. Nielsen, H. Solberg, P. Autzen, R.
Østerby, I.J. Christensen, T.H. Bugge, R.W. Stephens, et al. 2000. Lacta-
tional development and involution of the mammary gland requires plasmi-
nogen. Development. 127:4481–4492.
Lund, L.R., J. Romer, N. Thomasset, H. Solber, C. Pyke, M.J. Bissell, K. Dano,
and Z. Werb. 1996. Two distinct phases of apoptosis in mammary gland in-
volution: proteinase-independent and -dependent pathways. Development
(Camb.). 122:181–193.
Mayer, U., K. Mann, R. Timpl, and G. Murphy. 1993. Sites of nidogen cleavage
by proteases involved in tissue homeostasis and remodelling. Eur. J. Bio-
chem. 217:877–884.
Melino, G., and M. Piacentini. 1998. Tissue transglutaminase in cell death: a
downstream or a multifunctional upstream effector? FEBS Lett. 430:59–63.
Mudgett, J.S., N.I. Hutchinson, N.A. Chartrain, A.J. Forsyth, J. McDonnell, I.I.
Singer, E.K. Bayned, J. Flanagan, D. Kawka, C.F. Shen, et al. 1998. Suscepti-
bility of stromelysin-1–deficient mice to collagen-induced arthritis and carti-
lage destruction. Arthritis Rheum. 41:110–121.
Nagase, H. 1997. Activation of matrix metalloproteinases. Biol. Chem. 378:151–
160.
Neville, M.C., D. Medina, J. Monks, and R.C. Hovey. 1998. The mammary fat
pad. J. Mammary Gland Biol. Neoplasia. 3:109–115.
Ostrowski, L.E., J. Finch, P. Krieg, L. Matrisian, G. Patskan, J.F. O’Connell, J.
Phillips, T.J. Slaga, R. Breathnach, and G.T. Bowden. 1988. Expression pat-
tern of a gene for a secreted metalloproteinase during late stages of tumor
progression. Mol. Carcinog. 1:13–19.
Pujuguet, P., M. Simian, J. Liaw, R. Timpl, Z. Werb, and M.J. Bissell. 2000. Ni-
dogen-1 regulates laminin-1–dependent mammary-specific gene expression.
J. Cell Sci. 113:849–858.
Rajkumar, K., T. Modric, and L.J. Murphy. 1999. Impaired adipogenesis in in-
sulin-like growth factor binding protein-1 transgenic mice. J. Endocrinol.
162:457–465.
Ramirez-Zacarias, J.L., F. Castro-Munozledo, and W. Kuri-Harcuch. 1992.
Quantitation of adipose conversion and triglycerides by staining intracyto-
plasmic lipids with Oil Red O. Histochemistry. 97:493–497.
Ross, S.E., N. Hemati, K.A. Longo, C.N. Bennett, P.C. Lucas, R.L. Erickson,
and O.A. MacDougald. 2000. Inhibition of adipogenesis by Wnt signaling.
Science. 289:950–953.
Rudolph-Owen, L.A., D.L. Hulboy, C.L. Wilson, J. Mudgett, and L.M. Matri-Alexander et al. Stromelysin-1 Regulates Adipogenesis 703
sian. 1997. Coordinate expression of matrix metalloproteinase family mem-
bers in the uterus of normal, matrilysin-deficient, and stromelysin-1–defi-
cient mice. Endocrinology. 138:4902–4911.
Sato, H., T. Takino, Y. Okada, J. Cao, A. Shinagawa, E. Yamamoto, and M.
Seiki. 1994. A matrix metalloproteinase expressed on the surface of invasive
tumour cells. Nature. 370:61–65.
Selvarajan, S., L.R. Lund, T. Takeuchi, C.S. Craik, and Z. Werb. 2001. A plas-
minogen cascade dependent on plasma kallikrein is required for adipocyte
differentiation. Nat. Cell Biol. In press. 
Song, J., E. Sapi, W. Brow, J. Nilsen, K. Tartaro, B.M. Kacinski, J. Craft, F. Naf-
tolin, and G. Mor. 2000. Roles of Fas and Fas ligand during mammary gland
remodeling. J. Clin. Invest. 106:1209–1220.
Smas, C.M., and H.S. Sul. 1995. Control of adipocyte differentiation. Biochem.
J. 309:697–710.
Sternlicht, M.D., and Z. Werb. 1999. ECM proteinases. In Guidebook to the
Extracellular Matrix and Adhesion Proteins. T. Kreis and R. Vale, editors.
Oxford University Press, New York. 503–562.
Sternlicht, M.D., A. Lochter, C.J. Sympson, B. Huey, J.-P. Rougier, J.W. Gray,
D. Pinkel, M.J. Bissell, and Z. Werb. 1999. The stromal proteinase MMP3/
Stromelysin-1 promotes mammary carcinogenesis. Cell. 98:137–146.
Strange, R., F. Li, S. Saurer, A. Burkhardt, and R.R. Friis. 1992. Apoptotic cell
death and tissue remodelling during mouse mammary gland involution. De-
velopment (Camb.). 115:49–58.
Sympson, C.J., R.S. Talhouk, C.M. Alexander, J.R. Chin, S.M. Clift, M.J. Bis-
sell, and Z. Werb. 1994. Targeted expression of stromelysin-1 in mammary
gland provides evidence for a role of proteinases in branching morphogene-
sis and the requirement for an intact basement membrane for tissue-specific
gene expression. J. Cell Biol. 125:681–693.
Talhouk, R.S., M.J. Bissell, and Z. Werb. 1992. Coordinated expression of ex-
tracellular matrix-degrading proteinases and their inhibitors regulates mam-
mary epithelial function during involution. J. Cell Biol. 118:1271–1282.
Tenniswood, M.P., R.S. Guenette, J. Lakins, M. Mooibroek, P. Wong, and J.-E.
Welsh. 1992. Active cell death in hormone-dependent tissues. Cancer Me-
tastasis Rev. 11:197–220.
Thomasset, N., A. Lochter, C.J. Sympson, L.R. Lund, D.R. Williams, O. Beh-
rendtsen, Z. Werb, and M.J. Bissell. 1998. Expression of autoactivated
stromelysin-1 in mammary glands of transgenic mice leads to a reactive
stroma during early development. Am. J. Pathol. 153:457–467.
Tontonoz, P., E. Hu, and B.M. Spiegelman. 1995. Regulation of adipocyte gene
expression and differentiation by peroxisome proliferator activated receptor
gamma. Curr. Opin. Genet. Dev. 5:571–576.
Vu, T.H., J.M. Shipley, G. Bergers, J.E. Berger, J.A. Helms, D. Hanahan, S.D.
Shapiro, R.M. Senior, and Z. Werb. 1998. MMP-9/Gelatinase B is a key reg-
ulator of growth plate angiogenesis and apoptosis of hypertrophic chondro-
cytes. Cell. 93:411–422.
Vu, T.H., and Z. Werb. 2000. Matrix metalloproteinases: effectors of develop-
ment and normal physiology. Genes Dev. 14:2123–2133.
Wang, T.C., R.D. Cardiff, L. Zukerberg, E. Lees, A. Arnold, and E.V. Schmidt.
1994. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic
mice. Nature. 369:669–671.
Wang, Z., R. Juttermann, and P.D. Soloway. 2000. TIMP-2 is required for effi-
cient activation of proMMP-2 in vivo. J. Biol. Chem. 275:26411–26415.
Warburton, M.J., D. Mitchell, E.J. Ormerod, and P. Rudland. 1982. Distribu-
tion of myoepithelial cells and basement membrane proteins in the resting,
pregnant, lactating and involuting rat mammary gland. J. Histochem. Cy-
tochem. 30:667–676.
Weaver, V.M., and M.J. Bissell. 1999. Functional culture models to study mech-
anisms governing apoptosis in normal and malignant mammary epithelial
cells. J. Mammary Gland Biol. Neoplasia. 4:193–201.
Werb, Z. 1997. ECM and cell surface proteolysis: regulating cellular ecology.
Cell. 91:439–442.
Wiesen, J.F., and Z. Werb. 2000. Proteinases, cell cycle regulation and apopto-
sis during development and involution of the mammary gland. Mol. Reprod.
Dev. 56:534–540.
Will, H., S.J. Atkinson, G.S. Butler, B. Smith, and G. Murphy. 1996. The solu-
ble catalytic domain of membrane type 1 matrix metalloproteinase cleaves
the propeptide of progelatinase A and initiates autoproteolytic activation.
Regulation by TIMP-2 and TIMP-3. J. Biol. Chem. 271:17119–17123.
Witty, J.P., J.H. Wright, and L.M. Matrisian. 1995. Matrix metalloproteinases
are expressed during ductal and alveolar mammary morphogenesis, and mis-
regulation of stromelysin-1 in transgenic mice induces unscheduled alveolar
development. Mol. Biol. Cell. 6:1287–1303.
Ye, S., P. Eriksson, A. Hamsten, M. Kurkinen, S.E. Humphries, and A.M. Hen-
ney. 1996. Progression of coronary atherosclerosis is associated with a com-
mon genetic variant of the human stromelysin-1 promoter, which results in
reduced gene expression. J. Biol. Chem. 271:13055–13060.
Zhou, Z., S.S. Apte, R. Soininen, R. Cao, G.Y. Baaklini, R.W. Rauser, J. Wang,
Y. Cao, and K. Tryggvason. 2000. Impaired endochondral ossification and
angiogenesis in mice deficient in membrane-type matrix metalloproteinase I.
Proc. Natl. Acad. Sci. USA. 97:4052–4057.